contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-257-bavarian-nordic-roblon-og-gubra

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

CEO, Sweden

Claus Thestrup

Head of Research, Stables

Rasmus Køjborg

Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S.  Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark. 

Bavarian Nordic

Roblon develops high performance fiber solutions and technologies with a history dating back to 1957, when the company was founded.

Roblon produces the fibers, made of fiberglass, aramid etc. that are used to reinforce and protect vital cables in various industries.

The company is divided into two main business areas – Fiber Optic Cables (FOC) and Composite. The FOC segment is usually a sub-supplier to large cable producers, where the end customers are typically global internet and telecom providers. The Composite segment is usually a sub-supplier to the producers of wires and cables, which supply global oil & gas companies as well as companies that are active within wind energy.

Roblon is headquartered in Frederikshavn (Denmark) and has production facilities in Gærum (Denmark), Hickory, North Carolina (USA) and the recently acquired Vamafil in the Czech Republic. Roblon is thus active with production and sales in both Europe and the USA.

Roblon

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Gubra

Dagens aktienyheder med Bavarian Nordic, Roblon og Gubra

Bavarian Nordic lukkede i g&#xe5;r i kurs DKK 233 efter en kursstigning p&#xe5; +21%, da selskabet bekr&#xe6;ftede at der f&#xf8;res samtale om en mulig overtagelse af de to kapitalfonden Nordic Capital og Permira &#x2013; l&#xe6;s hele meddelelsen her: <a href="https://www.bavarian-nordic.com/investor/news/news.aspx?news=7256" target="_blank" rel="noopener">https://www.bavarian-nordic.com/investor/news/news.aspx?news=7256</a>
Vi afholder event med Bavarian Nordic i forbindelse med afl&#xe6;ggelse af deres halv&#xe5;rsregnskab den 26. august kl. 10 og du kan allerede nu tilmelde dig her: <a href="https://www.inderes.dk/videos/bavarian-nordic-fa-en-opdatering-pa-et-begivenhedsrigt-1-halvar-samt-2-kvartal-2025" target="_blank" rel="noopener">https://www.inderes.dk/videos/bavarian-nordic-fa-en-opdatering-pa-et-begivenhedsrigt-1-halvar-samt-2-kvartal-2025</a>
Roblon meddelte i g&#xe5;r at frasalget af selskabets amerikanske datterselskab er afsluttet pr. 24. juli 2025 under de hovedvilk&#xe5;r der blev skitseret i den hensigtserkl&#xe6;ring der blev offentliggjort i starten af juni i &#xe5;r. Frasalget af det amerikanske datterselskab, der blev igangsat i september sidste &#xe5;r, medf&#xf8;rer et tab p&#xe5; omkring DKK 31 mio., men hvor Roblon l&#xf8;bende vil modtage en r&#xe6;kke udest&#xe5;ender over de kommende &#xe5;r, og samtidig bibeholder en aktie i Roblon US med specielle rettigheder. K&#xf8;berne er to ledende medarbejdere.&#xa0;Du kan h&#xf8;re mere om frasalget og fremtiden for de forts&#xe6;ttende aktiviteter i Roblon i denne pr&#xe6;sentation fra offentligg&#xf8;relse af regnskabet for H1 2024/25 for lidt over en m&#xe5;ned siden: <a href="https://www.inderes.dk/videos/roblon-praesentation-af-regnskabet-for-2-kvartal-202425">https://www.inderes.dk/videos/roblon-praesentation-af-regnskabet-for-2-kvartal-202425</a>
Investeringsbanken Goldman Sachs indleder d&#xe6;kning p&#xe5; Gubra med anbefalingen Neutral og et kursm&#xe5;l p&#xe5; DKK 520 pr. aktie. Gubra lukkede i g&#xe5;r i kurs DKK 419,80.
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale. /Rasmus K&#xf8;jborg d. 25/07-2025 kl. 8:50.

Dagens aktienyheder 25/7: Bavarian Nordic, Roblon og Gubra

Stay up to date